After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

This technology holds promise for refining clinical pathways in cardiovascular care, enhancing both diagnostic precision and patient outcomes. Future studies should explore its broader application in ...

Therefore, our endeavor to explore novel insights into the cellular and molecular mechanisms of endothelial dysfunction is crucial for the field. We first discovered that the high glucose treatment ...

State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Centre for New Organic Matter, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Centre for Analytical ...

Hebei Key Laboratory of Colorectal Cancer Precision Diagnosis and Treatment, The First Hospital of Hebei Medical University, Shijiazhuang, China Introduction: In thyroid carcinoma (TC), follicular ...

Among patients who had MIBC, the median time to correct treatment was significantly shorter with Pathway 2 than with Pathway 1 — 53 days and 98 days, respectively (P =.02). Among patients with ...

Want to apply for Canada PR? The country is set to introduce four new permanent residency (PR) pathways in 2025, even as the government plans to reduce its PR targets from 485,000 to 465,000, ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Treatment with the CAR-T cell therapy Yescarta (axicabtagene ciloleucel) continued to demonstrate durable responses after a median follow-up of more than five years in patients with ...

Rik Bryan, professor in urothelial cancer research and director of the Bladder Cancer Research Centre at the University of Birmingham said the standard initial treatment pathway for bladder cancer ...